Medasense: Funding, Investors & Team (Sep 2026)
Medasense has developed a groundbreaking technology, the PMD-200 with its NOL® index, that allows healthcare providers to personalize pain management without overmedicating patients. This innovative platform uses artificial intelligence and a non-invasive sensor to objectively monitor and quantify a patient's pain response, particularly in situations where communication is difficult. The PMD-200 is currently being used in operating rooms and critical care settings, with plans to expand into the broader healthcare market. Partnering with companies like Medtronic and Philips, Medasense is committed to improving patient safety and outcomes by reducing opioid use. Founded in 2008, Medasense is headquartered in Ramat Gan, Tel Aviv, Israel.
Medasense has raised $18.0M across 2 funding rounds on record, the most recent an undisclosed round announced in Jan 2025.
Medasense Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Medasense Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Medasense raised $18.0M in an undisclosed round announced in Sep 2020.
4.3 years later, an undisclosed round was announced in Jan 2025 with no disclosed amount.
Medasense Founders and Leadership Team
Contact details for the Medasense team: 1 of 1 has an email address on file.
Start 14-day free trial →Medasense Funding Compared to Other Artificial Intelligence Startups
Funded Startups Like Medasense in Artificial Intelligence and Ramat Gan
Companies Similar to Medasense
Faye provides whole-trip travel coverage and care that brings out the best in each journey with…
Arato.ai is an advanced AI agent simulation platform that helps organizations test, evaluate, and monitor…
Kinoa provides an AI-powered LiveOps platform that helps mobile app and game companies manage user…
Dream Security is a cybersecurity firm that creates artificial intelligence products to safeguard against…
SuperBuzz (TSXV: SPZ) utilizes cutting-edge GPT-3 technology, such as chatGPT, to produce targeted content…
Limitless Labs is an AI-powered technology intended to improve CNC machining operations. It offers an AI CAM…
NewCore is a security-first identity platform that governs every human and AI agent identity for the…
Odysight.AI is an AI platform that specializes in visualizing, analyzing, predictive maintenance, and…
Arito is an AI-powered finance platform that helps teams automate reporting, analyze data, and generate…
Cybord creates technologies that prevent fake, substandard, and harmful electronic parts from being…
The ThirdEye Team believes that today's drones have amazing capabilities and should be accessible by almost…
The unique computational solution provided by Scala Biodesign enhances the worth of proteins and speeds up…
Medasense Funding FAQs
What does Medasense do?
Medasense has developed a groundbreaking technology, the PMD-200 with its NOL® index, that allows healthcare providers to personalize pain management without overmedicating patients. This innovative platform uses artificial intelligence and a non-invasive sensor to objectively monitor and quantify a patient's pain response, particularly in situations where communication is difficult. The PMD-200 is currently being used in operating rooms and critical care settings, with plans to expand into the broader healthcare market. Partnering with companies like Medtronic and Philips, Medasense is committed to improving patient safety and outcomes by reducing opioid use. Founded in 2008, Medasense is headquartered in Ramat Gan, Tel Aviv, Israel.
How much funding has Medasense raised?
Medasense has raised $18.0M across 2 rounds on record.
When did Medasense last raise funding?
Medasense's most recent funding round on record was announced in Jan 2025. The amount was not disclosed.
Who founded Medasense?
FundedIQ lists Galit Zuckerman (Founder) at Medasense.
Where is Medasense headquartered?
Medasense is based in Ramat Gan, Tel Aviv, Israel.
How many employees does Medasense have?
Medasense is in the 11-50 employee band.
About FundedIQ's Medasense Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Medasense is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.